Linguistic Validation of the Japanese Version of the Multidimensional Dyspnea Profile and Relation to Physical Activity in Patients with COPD.

PURPOSE: This study aimed to develop a linguistically validated Japanese translation of the multidimensional dyspnea profile (MDP) and assess whether worsening of dyspnea's sensory and affective domains during exercise had detrimental effects on physical activity in stable outpatients with chronic obstructive pulmonary disease (COPD).
MATERIALS AND METHODS: The Japanese version of the MDP was prepared in collaboration with Mapi Research Trust (Lyon, France) after the approval of the developer. Physical activity was assessed using a 3-axis accelerometer. Dyspnea upon exertion was investigated using a 3-minute step test.
RESULTS: The Japanese version of the MDP was obtained and validated linguistically. Air-hunger was significantly associated with total calories from walking (r = - 0.47, p < 0.05), while anxiety and depression were significantly correlated with both the amount and intensity of physical activity (r = - 0.49, p < 0.05, and r = - 0.46, p < 0.05, respectively).
CONCLUSION: The Japanese version of the MDP was suggested to reflect both pulmonary functions, ventilatory response during exercise, and intensity and amount of physical activity in patients with COPD.

Introduction

Dyspnea is a qualitatively distinct subjective sensation of breathing discomfort.1 The various sensory qualities of dyspnea have different physiological and emotional consequences, because it is the need for air, but not the sensation of effort while breathing, which induces an unpleasant sensation.2 Identifying the sensory and affective components of dyspnea is clinically relevant in managing patients with chronic obstructive pulmonary disease (COPD) who complain of dyspnea during daily physical activity.

Physical inactivity can lead to exacerbation and mortality in patients with COPD;3–6 but, many patients limit their physical activity mainly to avoid dyspnea.7 There is accumulating evidence that shows physical activity is an important clinical outcome in patients with COPD.8 Among the various contributing factors, the effect of breathlessness on physical activity has been a matter of concern.6,7 Exertional dyspnea consists of qualitatively distinct sensations that vary in intensity.9,10 In particular, a robust inspiratory neural drive upon exertion contributes to the magnitude of dyspnea,11 whereas a restricted inspiratory volume expansion against the increasing neural respiratory drive and afferent chemoreceptor stimulations lead to air hunger.12 Considering that air hunger is more unpleasant than work effort to breathe, affective domains such as anxiety and fear during exercise testing may reflect a subjective affective experience of dyspnea during daily physical activities.10,13 Therefore, understanding the sensory and affective elements of dyspnea upon fixed exercise stimulus can play a crucial role in increasing physical activity in patients with COPD.

Banzett et al developed the Multidimensional Dyspnea Profile (MDP), designed to assess immediate breathing discomfort, sensory quality (SQ), and emotional impact of dyspnea during a specific time period.14 Because the words used to express breathing sensations may differ,15 various versions of the MDP have been widely translated and validated, such as the Danish,16 Swedish,17 German,18 or Portuguese versions.19 However, most available instruments in Japanese assess dyspnea only using a mono-dimensional approach. Therefore, there is a need for an instrument in the Japanese language to evaluate and distinguish multiple aspects of dyspnea at a specific period.

Accordingly, this study aimed to develop a linguistically validated Japanese translation of the MDP and assess whether worsening of dyspnea’s sensory and affective domains upon exercise stimulus had detrimental effects on physical activity in stable outpatients with COPD.

Materials and Methods

Translation

Structured translation and linguistic validation of the MDP from US English to Japanese was approved by the developer (Robert B. Banzett) and conducted in collaboration with a company specializing in translation and linguistic validation of patient-reported outcome measures (Mapi SAS, Language Services Unit, Lyon, France). In addition, the algorithm of the linguistic validation process was conducted in a structured, multistage process according to International guidelines.20,21 It consisted of a forward-translation, backward-translation and a cognitive interview step.

After obtaining permission for translation, the original MDP was obtained from the developer. The original was forward-translated into Japanese by two independent professional translators as follows: native American English and Japanese bilingual speakers (Ulatus, Crimson Interactive Pvt. Ltd, Mumbai, India). The forward-translated MDP was analyzed and adjusted by in-country consultants (MK, AT, SE), who provided detailed feedback on the understandability and validity of critical concepts to tool users and people with dyspnea. Forward-translators and in-country consultants discussed all translations and agreed on a reconciled version (version 1) and submitted by MK to the Mapi Research Trust.

To return the first version of the MDP into the source language (version 2), we recruited a native American English and Japanese bilingual speaker (Ulatus, Crimson Interactive Pvt. Ltd, Mumbai, India). The translator for backward translation had no access to the original version. In-country consultants performed a comparison of backward performance with the original MDP. The local coordinator (MK) could contact the backward translator if needed. After submitting the backward translation to Mapi, the developer reviewed it to detect any misunderstandings, mistranslations, or inaccuracies in the first MDP version. Finally, MK submitted a report on the second version of Mapi Research Trust (version 3). Translation version 3 was evaluated through cognitive interviews with five patients with COPD. All participants commented on their understanding of each item. After revising and proofreading, a final linguistically validated translation was issued.

Ethics Approval

The study was approved by the institutional ethics review board of Himeji Dokkyo University (Himedookusei-19-10) and was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained in the form of opt-out by displaying a notice at the clinic.

Study Population: MDP and Physical Activity in COPD

We contacted 20 patients with stable COPD who had regular outpatient visits at a general practice and respiratory clinic and who agreed to be enrolled in the cross-sectional study. Patients with COPD were diagnosed according to the guidelines of the Japanese Respiratory Society,22 which was based on a long-term history of smoking, FEV1/FVC < 70% by spirometry after bronchodilator inhalation, and exclusion of other diseases that could cause airflow obstruction. The exclusion criteria were an inability to perform the 3-minute step test, active cardiovascular comorbidity (ie severe heart failure with reduced left ventricular ejection fraction, cardiomyopathy, recent acute myocardial infarction, cardiac arrhythmias, or stroke), long-term use of oxygen therapy, or other conditions that could affect dyspnea or exercise capacity.

The patients initially underwent spirometry measurements (CHESTGRAPH HI-301U; Chest Co., Tokyo, Japan) and maximal inspiratory pressure (PI, max) measurements. PI, max was measured at functional residual capacity using the POWERbreathe KH2 device (POWERbreathe International Ltd.). The inspiratory maneuvers were performed with the patient seated and wearing a nose clip. The maneuvers were repeated at least five times until three reproducible efforts (ie < 10% variance) were obtained.23

Appendicular skeletal muscle mass loss was assessed using multifrequency bioelectrical impedance analysis (InBody 470, InBody Japan, Tokyo, Japan). Appendicular skeletal muscle mass was calculated as the sum of the muscle masses of the four limbs, from which the appendicular skeletal muscle mass index was calculated. Quadriceps strength was assessed by the peak force obtained from the isometric maximum knee extension in a sitting position using a belt-fixed hand-held dynamometer (μ-Tas F-1, Anima, Tokyo, Japan). Handgrip strength was evaluated in a standing position with the elbow straight and the arm held to the body (T.K.K.5401; Takei Kiki Kogyo, Niigata, Japan).9 Three measurements were performed, and the highest value was recorded.

Constant-Rate Step Test Protocol

Constant-exercise testing was performed using the 3-minute step test protocol, consisting of 3-minute bouts of exercise at externally paced stepping rates of 16 steps per minute, as described by Borel et al24 Respiratory flow was measured at rest and during the 3-minute step test through a respiratory flow head (MTL-300L, AD Instruments Ltd, Chalgrove, United Kingdom) attached to a face mask.9 Inspiratory capacity maneuvers were performed at rest and the end of the 3-minute step test.9 Immediately after each 3-minute step test, the qualitative sensory and affective dimensions of dyspnea were evaluated for each patient using a Japanese MDP questionnaire.14 The investigator instructed patients to focus on the end of the 3-minute step test when supplying ratings and selecting feelings. The investigator explained each multidimensional dimensional profile question to every patient.14

Physical Activity Measurement

The Active Style Pro (HJA-750C®, Omron Healthcare Inc., Kyoto, Japan) with triaxial acceleration can be worn around the waist and continually records physical activity for two weeks.25 This physical activity meter has been validated26 and widely used in healthy and elderly people27 and patients with COPD.28 Each participant was instructed to wear the device for at least 10 hours without sleeping while awake and to avoid water-use activities such as bath time. Ten or more hours of accelerometer wear time per day was considered valid. We measured the number of daily steps and metabolic equivalents (METs) and calculated the total calories consumed due to walking and lifestyle activities.

Statistical Analyses

Data are presented as means and standard errors. A priori sample size calculation was performed (G*Power3.1.9.2; Universität Kiel) using data from the preliminary investigation and using the previous experimental model in which investigators reported medium to large effect sizes. This indicated that we would need 17 subjects as a total sample size to find statistical significance with an effect size of 0.6, a power of 0.8, and an alpha set to 0.05. Maximal voluntary ventilation (MVV) was calculated from 35 times the FEV1 value. The relationship between MDP score and pulmonary function, ventilatory response, and physical activity was analyzed using Spearman’s rank correlation coefficient. P values < 0.05 were regarded as statistically significant. Analyses were performed using SPSS (version 27; IBM Corp., Armonk, NY, USA).

Results

A copy of the final certified, linguistically validated Japanese translation of the MDP was developed. The Japanese version of the MDP was produced through forward-translation, backward-translation, and cognitive interviews with patients. It consists of four pages: the first is the A1 scale for measuring discomfort or unpleasantness, the second is the SQ scale for selecting five sensory types, the third measures the intensity of each sensation, and the fourth is the intensity of five emotional items. The MDP item ratings follow a 0–10 scale: A1: 0 = neutral; 10 = unbearable; SQ: 0= none, 10 = as intense as I can imagine; A2: 0 = none, and 10 = the highest I can imagine.

Patients

Twenty patients with COPD were enrolled in this study. The characteristics of pulmonary function, body composition, and muscle strength are shown in Table 1. The participants comprised 80% males and 74.5 ± 1.22 years old, on average. The median body mass index was 22.0 ± 3.67 (kg/m2). Appendicular skeletal muscle mass index and handgrip strength were 6.65 ± 1.01 and 30.5 ± 8.22 (kg), respectively.

Table 1

Characteristics of Patients with Chronic Obstructive Pulmonary Disease

Variable	Mean	SD
Age (years)	74.5	5.45
Height (cm)	161.4	7.99
Weight (kg)	57.7	11.3
Body mass index (kg/m2)	22.0	3.67
Appendicular skeletal muscle mass (kg)	22.5	4.27
Fat-free mass (kg)	41.7	7.24
Appendicular skeletal muscle mass index	6.65	1.01
FEV1 (L)	1.45	0.65
FVC (L)	2.76	0.73
FEV1 (%)	60.2	24.50
FVC (%)	87.5	16.85
IC (L)	1.99	0.51
PI, max (cmH2O)	69.2	30.22
Handgrip strength (kg)	30.5	8.22
Quadriceps strength (kg)	27.7	9.00

Note: Data are expressed as the means and standard deviations.

Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced volume capacity; IC, inspiratory capacity; PI, max, maximal inspiratory pressure.

Relationship Between the Japanese Version of the MDP and Pulmonary Function and Ventilatory Response with Exercise

Table 2 shows the ventilatory and multidimensional dyspnea profiles in response to the 3-minute step test. As shown in Table 2, dynamic lung hyperinflation was − 0.10 ± 0.29 (L) and VE/MVV was 32.8 ± 30.9, suggesting that restriction of ventilation during exercise was mild. Regarding the sensory dimension of dyspnea after the 3-minute step test, physical breathing effort was the only variable showing a significant negative correlation with IC immediately after the 3-minute step test (r = − 0.530, p < 0.05). Air hunger after the 3-minute step test was significantly correlated with %FEV1 and FEV1% (Table 3). Sense of hyperpnea was significantly associated with inspiratory time and the ratio of inspiratory time to one breath. Regarding the affective dimension of dyspnea after the 3-minute step test, depression was found to be associated with IC, inspiratory muscle strength, and ventilation after the 3-minute step test, and dynamic hyperinflation on exertion; anxiety was associated with ventilation and IC after the 3-minute step test (Table 3).

Table 2

Ventilatory and Multidimensional Dyspnea Profile in Patients with Chronic Obstructive Pulmonary Disease

	Ventilatory Response at the End of the Exercise	Mean	SD
	VT (L)	0.96	0.35
	VE (L)	23.7	8.00
	VE/MVV (%)	32.8	30.9
	IC at rest (L)	1.92	0.56
	IC at the end of exercise (L)	1.75	0.56
	Change in IC (L)	−0.10	0.29
Multidimensional Dyspnea Profile
Sensory dimension
SQ scale
	Physical breathing effort	1.4	1.90
	Air hunger	2.0	2.87
	Tightness	0.8	1.37
	Mental breathing effort	1.6	2.62
	Hyperpnea	2.2	2.80
	Sum of sensory categories	7.8	7.49
Affective dimension
A1 scale	Unpleasantness	4.1	2.33
A2 scale	Depressed	1.8	2.00
	Anxious	0.4	1.05
	Frustrated	0.2	0.62
	Angry	0.1	0.45
	Afraid	0.5	1.28
	Sum of affective categories	2.9	3.85

Note: Data are expressed as the means and standard deviations.

Abbreviations: VT, tidal volume at the end of the exercise; VE, minute ventilation at the end of the exercise; MVV, maximal voluntary ventilation; IC, inspiratory capacity.

Table 3

Correlation Coefficients Between Multidimensional Dyspnea Profile and Pulmonary Function and Exertional Ventilatory Response in Patients with Chronic Obstructive Pulmonary Disease

	%FEV1	%FVC	FEV1%	IC	PI, max	VE	tI	tI/ttot	VT/tI	The Change in IC
Physical breathing effort	−0.23	−0.42	−0.26	−0.12	−0.12	−0.22	−0.46	−0.14	−0.04	−0.08
Tightness	−0.13	−0.08	−0.18	0.07	−0.08	0.21	−0.33	0.06	0.07	0.04
Air hunger	−0.60**	−0.44	−0.47*	−0.35	−0.32	−0.24	−0.30	0.1	−0.18	0.12
Mental breathing effort	−0.19	−0.04	−0.24	−0.06	−0.13	−0.16	−0.47	−0.07	0.12	0.09
Hyperpnea	−0.11	0.16	−0.32	0.11	0.17	0.44	−0.50	−0.53*	0.75**	−0.07
Sum of sensory categories	−0.54*	−0.30	−0.58**	−0.30	−0.21	0.04	−0.63*	0.06	0.06	0.15
Unpleasantness	–0.19	0.15	−0.17	−0.37	−0.40	0.12	−0.64*	0.04	0.17	0.45
Depressed	−0.04	0.21	−0.16	0.73**	0.57*	0.47*	0.4	−0.42	0.32	−0.47*
Anxious	0.34	0.37	0.23	0.531*	0.39	0.51*	0.07	−0.38	0.46	−0.06
Frustrated	0.1	−0.02	0.22	0.3	0.26	0.09	0	−0.31	0.12	−0.40
Angry	−0.09	−0.15	−0.03	0.35	0.28	0.22	−0.14	−0.14	0.09	−0.44
Afraid	0.02	0.03	0	0.41	0.19	0.44	−0.29	−0.18	0.33	−0.23
Sum of affective categories	0.01	0.2	−0.11	0.76**	0.57*	0.58**	0.18	−0.40	0.41	−0.45

Notes: Data represent the Spearman correlation coefficient. *And the bold font denote p-value less than 0.05. **And the bold font denote p-value less than 0.01.

Abbreviations: VT, tidal volume at the end of the exercise; VE, minute ventilation at the end of the exercise; IC, inspiratory capacity; tI, inspiratory time; tI/ttot, duty cycle; VT/tI, inspiratory flow rate.

Relationship Between the Japanese Version of the MDP and Physical Activity

Table 4 shows the details of the physical activity. Concerning the sensory dimension of dyspnea, the air hunger after the 3-minute step test showed a significant negative correlation with the calories consumed during walking (Table 5). In contrast, with respect to the affective aspect of dyspnea, depression was found to be significantly correlated with total calories and physical activity duration at intensities ≥ 5 MET (Table 5). Anxiety in the 3-minute step test was found to be significantly negatively correlated with the total calories consumed during walking (Table 5).

Table 4

Characteristics of Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

Intensity of Physical Activity	Mean	SD
>1 MET (min/day)	610.4	219.0
>2 MET (min/day)	193.1	96.8
>3 MET (min/day)	54.1	34.0
>4 MET (min/day)	13.4	12.0
>5 MET (min/day)	2.7	2.5
Amount of physical activity
Total calories from walking (kcal/day)	100.4	58.0
Total calories from lifestyle activities (kcal/day)	355.1	148.8
The number of daily steps (step/day)	3866.6	3370.1

Note: Data are expressed as the means and standard deviations.

Abbreviation: MET, metabolic equivalents.

Table 5

Correlation Coefficients Between Multidimensional Dyspnea Profile and Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

	>1 MET (min)	>2 MET (min)	>3 MET (min)	>4 MET (min)	>5 MET (min)	>6 MET (min)	>7 MET (min)	Total Calories Consumed Due to Walking (kcal)	Total Calories Consumed Due to Lifestyle Activities (kcal)	Number of Daily Steps (Step)
Physical breathing effort	0.3	0.28	0.34	0.15	0.35	0.12	0.41	0.19	0.34	0.34
Air hunger	0.31	0.2	−0.12	−0.11	−0.17	−0.12	–0.17	–0.47*	0.37	−0.11
Tightness	0.41	0.15	−0.05	−0.16	−0.07	0.13	0.34	−0.12	0.18	0.89
Mental breathing effort	0.19	−0.02	−0.21	−0.13	0.07	−0.07	−0.26	−0.28	0.1	−0.15
Hyperpnea	0.17	0.26	0.03	0.01	−0.23	−0.38	−0.20	−0.18	0.41	−0.21
Unpleasantness	−0.14	0.14	0.21	0.33	0.12	0	−0.13	0.09	0.06	−0.01
Depressed	0.19	0.15	0	−0.15	−0.49*	−0.26	−0.03	−0.05	0.33	0.03
Anxious	0.24	−0.11	−0.22	−0.14	−0.32	−0.07	0.1	−0.44	−0.46*	−0.26
Frustrated	0.06	−0.20	−0.17	−0.35	−0.12	0.26	0.45*	−0.09	−0.03	−0.29
Angry	0.18	−0.18	−0.30	−0.30	−0.06	0.22	0.36	−0.34	0.06	−0.3
Afraid	0.21	−0.12	−0.14	−0.21	−0.19	0.21	0.4	−0.25	0.09	−0.15

Notes: Data represent Spearman correlation coefficients. *And the bold font denote p-value less than 0.05.

Abbreviation: MET, metabolic Equivalent.

Discussion

To the best of our knowledge, the Japanese version of the MDP is the first instrument to examine the sensory and affective dimensions of dyspnea during a specific period determined by the user. Dyspnea is a distressing symptom in patients with COPD. Identifying the intensity and SQ of dyspnea is clinically relevant because the physiological and emotional consequences of various dyspnea types differ.2 Therefore, a more precise characterization of the sensory and affective dimensions of dyspnea using the Japanese version of the MDP could help develop better approaches to control dyspnea in a clinical setting.

This study examined only the Japanese linguistic validity of the MDP. To examine whether the individual question items included in the Japanese version of the MDP have internal consistency, Cronbach’s alpha reliability coefficients may be determined. However, the magnitude of dyspnea during inspiratory resistive breathing has been reported to decrease in males and increase in females with each breath.29 Considering that the MDP assesses sensory and emotional aspects of dyspnea at a specific period, it is difficult to determine the difference between the first experimentally induced and repeated dyspnea in the same participant, given the nature of the modifying effects of dyspnea as described above.

Although physical activity is influenced by multidimensional elements, breathlessness is one of the major limiting factors.7 The present study examined the effects on physical activity of the sensory and emotional aspects of dyspnea after an identical exercise load using the Japanese version of the MDP. It was found that the sensation of air hunger was negatively associated with the amount of energy spent walking (calories), indicating that air hunger contributed to the avoidance of physical activity. Furthermore, the effect of the emotional aspects of dyspnea on both the amount and intensity of physical activity suggests the need for intervention in these aspects.

The emotional aspect of breathlessness after the 3-minute step test was mild; but, anxiety and depression after the 3-minute step test significantly correlated with physical activity. The scores on the emotional aspect of dyspnea during exercise in patients with COPD are known to be relatively mild.9,30 However, despite the mild intensity of the emotional aspect of dyspnea, a recent study has shown that the exertional affective dimension of breathlessness is associated with COPD exacerbation.10 This suggests that the emotional aspects of breathlessness upon physical activity and exercise loading need to be carefully evaluated to prevent exacerbations.

Air hunger was associated with FEV1 (%) but not with dynamic lung hyperinflation. Air hunger can be caused by an inadequate ventilatory response to respiratory drive; the VE/MVV at the end of the 3-minute Step Test was 32.8 ± 7.49 %, suggesting that the inadequate ventilatory response to respiratory drive was mild. The change in IC before and after exercise was also modest, suggesting that it was linked to mild air hunger. However, regardless of the modest air hunger upon exertion, the association between air hunger and FEV1 (%) suggests that it is an important finding in determining the therapeutic effect of bronchodilation.

The present study suggested that the time of physical activity intensity of 1 and 2 METs to the total was greater and intense physical activity was lower. This observation is consistent with studies showing that COPD patients have more sedentary time and less physical activity than asthmatic and bronchiectasis patients.31 However, we observed no association between exertional multidimensional dyspnea characteristics and the duration of low-intensity activity. This could indicate that improvement in breathlessness was not a significant contributor to the improvement in low-intensity physical activity.

The Japanese version of the MDP was completed within a few minutes by most participants. The MDP and all its derivative works are copyrighted by the developers, and the original reference should be cited by all papers using MDP.2 The original MDP and all its translations were distributed by the Mapi Research Trust (), which should be contacted for any inquiry about the questionnaire and the requirements regarding its use.

The limiting factor in this study was the small sample size of the population, which only allowed us to examine univariate relationships. In addition, the study included female patients with COPD, and there may be gender effects on physical activity and multidimensional dyspnea properties. Therefore, future studies with larger numbers of patients are warranted.

Conclusion

In this study, we developed a linguistically validated Japanese translation of the MDP. The results suggest that air hunger is associated with avoidance of physical activity, while the emotional aspects of dyspnea affect both the amount and intensity of physical activity; therefore, a detailed assessment of multidimensional aspects of dyspnea is needed in clinical situations.

Summary at Glance

This study is the linguistic validation of the Japanese version of the multidimensional dyspnea profile and the first study to investigate the relationship between exertional multidimensional dyspnea and the profile of physical activity in patients with COPD.